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INTRODUCTION 
Lower urinary tract symptoms (LUTS) have an increasing prevalence in 
ageing men and women. Men who present with LUTS are investigated 
for benign prostatic enlargement (BPE) and bladder outlet obstruction 
(BOO), both of which are usually the result of benign prostatic 
hyperplasia (BPH). 1 Bladder outlet obstruction is the generic term for 
obstruction during voiding and is characterized by increased detrusor 
pressure and reduced urinary flow rate. 
    However, LUTS alone are not sufficient in diagnosing benign prostatic 
enlargement or bladder outlet obstruction and other investigations are 
usually required. 2 In patients with BPH, no strict relationship between 
LUTS, BPE, and BOO has been found so far. 
Uroflowmetry is a economic test which provides some information on 
the voiding function and is easy to perform in the outpatient setting. 
However, it lacks the required specificity as it is unable to differentiate 
between bladder outlet obstruction and detrusor underactivity. 
Conversely, pressure-flow studies remain the reference gold standard 
test in diagnosing bladder outlet obstruction as they are able to provide 
valuable information on the detrusor contractility as well as the presence 
or absence of obstruction. This, unfortunately, does not come easily as 
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urodynamics are invasive tests and require specialist equipment and 
training to perform the tests and interpret the results. 3 . Thus, a 
noninvasive, quick, inexpensive and easily available diagnostic tool 
with a high sensitivity and specificity for determining bladder outlet 
obstruction would be ideal .The quest for a non-invasive test diagnostic 
of bladder outlet obstruction has been ongoing for many years. Many 
parameters were investigated including free uroflowmetry, post-void 
residual volume and quantification of prostate volume.4  Over the past 
decade , interest into bladder wall thickness [BWT]and consequently 
bladder wall weight has grown rapidly. In a recently published meta-
analysis of all available noninvasive tests for bladder outlet obstruction 
evaluation, ultrasound measurements of bladder  wall thickness and 
bladder weight were the only promising methods with a good evidence 
base to support their use in entering clinical practice after further 
evaluation. This was based on the rationale that bladder outlet 
obstruction is associated with detrusor hypertrophy and an increase in 
bladder wall thickness. In fact, morphological studies showed that the 
increase in bladder wall thickness was the result of smooth muscle 
hypertrophy as well as increased collagen deposition in the bladder 
wall.5  we estimated the diagnostic accuracy of ultrasound 
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bladder wall thickness and bladder weight measurement for bladder 
outlet obstruction and investigated whether this method can replace 
pressure flow studies [PFS] in diagnosing bladder outlet obstruction. 
Therefore, the aim of our study is to prospectively evaluate the 
diagnostic accuracy of ultrasound estimated bladder weight [UEBW ] in 
patients with clinical BPH and history of obstructive LUTS to diagnose 
bladder outlet obstruction  as defined by pressure–flow 
analysis(reference standard).we also studied the relevance of Bladder 
wall thickness[BWT] measurements, International prostate symptom 
score [IPSS ], uroflowmetry, postvoid residual urine[PVR], and prostate 
volume (index tests) in our patients with clinical BPH and history of 
obstructive LUTS to diagnose bladder outlet obstruction as defined by 
pressure–flow analysis(reference standard). 
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AIM AND OBJECTIVE 
 
The aim of this study is  
 
1) To study the use of ultrasound estimated bladder weight in 
diagnosing bladder outlet obstruction in men with benign 
prostatic enlargement and obstructive  lower urinary tract 
symptoms. 
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REVIEW OF LITERATURE 
Benign prostatic hyperplasia and other disorders can cause mechanical 
bladder outlet obstruction. Such an outlet obstruction can in turn cause 
hypertrophy of the bladder detrusor muscle, which may lead to 
additional irritative urinary symptoms. Such a hypertrophy manifests as 
increased detrusor wall thickness and an increased bladder weight. A 
recently published article, which reviewed the morphologic and 
functional changes of the bladder wall in response to bladder outlet 
obstruction, describes comprehensively how mechanical stretch induces 
gene expression and protein synthesis in the epithelium and smooth 
muscle cells, and explains how bladder outlet obstruction could cause 
lower urinary tract symptoms 
Ultrasound emerged as the easiest and least invasive option in 
measuring bladder wall thickness. The bladder wall appears on 
ultrasound as a three layer structure with the detrusor muscle 
represented by a hypoechogenic layer between two hyperechogenic 
layers representing the serosa and mucosa . 6 Some investigators 
measured the thickness of the three layers together, 7 whilst others used 
the middle detrusor layer only. 8 Most studies used the anterior bladder 
wall by transabdominal ultrasound, however, some used the posterior 
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bladder wall by transrectal or transvaginal ultrasound . 9 Studies have 
shown that there are no significant differences in the thickness of either 
anterior or posterior wall of the bladder . 10,11 
Ultrasound imaging  depends on the frequency of the ultrasound waves 
used; the higher the frequency, the better the resolution of the image but  
lower the depth of penetration. 12 Oelke et al. suggested that it is 
necessary to use high-frequency ultrasound arrays (7.5 MHz or higher) 
with an enlargement function of the ultrasound picture for precise 
measurement of bladder wall thickness (BWT).8 The problem with 
bladder wall thickness is that it is volume dependent; wall thickness 
decrease with increasing filling volume. Oelke et al. studied 9 
volunteers with normal urodynamics and found that bladder wall 
thickness decreased rapidly during the first 250 ml of bladder filling. 8 
This prompted others to investigate bladder wall weight as a measure of 
bladder hypertrophy which should remain constant at different bladder 
volumes. 10 Again for measuring bladder wall thickness,both two 
dimensional B-mode and three dimensional    V-mode ultrasound can be 
used, each having its own merits and demerits. 
.Adequate noninvasive methods for diagnosing these conditions do not 
exist and, thus, pressure volume studies of filling and pressure flow 
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studies of voiding remain the gold standard investigations. However, 
these tests are invasive, expensive and time-consuming with associated 
morbidity.¹³ Animal studies have revealed bladder wall hypertrophy and 
increased bladder weight after partially induced bladder outlet 
obstruction,14-18 within as little as 2 weeks.5 Mean bladder wall thickness 
in control, partially obstructed and severely obstructed rabbits was 1.57, 
2.04 and 2.77 mm, respectively, with most thickening in the detrusor 
layer.15 Histological analysis showed smooth muscle cell hypertrophy 
and hyperplasia, and increased collagen deposition, ratio of type I-to-III 
collagen 15,18 and muscarinic cholinergic receptors.16 Similar histological 
patterns were observed in patients with bladder outlet obstruction 19,20 
and detrusor overactivity [DO] 21, and in those undergoing augmentation 
surgery for high intravesical pressure. 22 Furthermore,bladder weight, 
smooth muscle cell hypertrophy and collagen deposition have been 
shown to partially reverse after BOO relief in pigs.17 Beamon et al 
demonstrated concurrent development of detrusor hypertrophy and 
detrusor overactivity with induced BOO in mice at 6 weeks, which is a 
well-known association in clinical practice.18 .Historically urologists 
believed bladder trabeculation to be a marker of bladder outlet 
obstruction. Although studies have confirmed this 
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 relationship, 19,23  in some cases detrusor overactivity and not bladder 
outlet obstruction  may be the causative factor.24  Bladder wall 
hypertrophy can be visualized on ultrasound. Ultrasonic measurements 
of bladder wall thickness and bladder weight can distinguish between 
obstructed and nonobstructed rabbit bladders.25 In the last decade 
increasing interest has arisen in the measurement of bladder wall 
thickness and the ultrasound estimation of bladder weight as a 
noninvasive  means of assessing lower urinary tract symptoms. 
However, to date such measurements have not been adopted into clinical 
practice 
 
BWT/DWT in Healthy Asymptomatic Adults 
Before ultrasound measurement of BWT/DWT can be used as a reliable 
clinical tool, the quantification of these measurements in the 
healthy,asymptomatic population must be established. However, reports 
on normal measurements are few and difficult to compare because of 
fundamental differences among them, particularly for BWT or DWT 
and the degree of bladder filling at which such measurements should be 
taken. On transabdominal ultrasound (TAUS) at a variety of filling 
volumes in asymptomatic healthy volunteers mean bladder wall 
thickness [BWT] was 3.33 and 3.04 mm in 172 men and 166 women, 
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respectively.26 This gender difference was also observed in measurement 
of the detrusor layer in 55 healthy volunteers, with a mean DWT of 1.4 
and 1.2 mm in males and females, respectively, measured at a bladder 
volume of 250 ml or greater 8  Measurement of DWT was considered 
preferable to total bladder wall thickness for two reasons. 1) Previous 
animal studies have shown  the muscle layer to be mostly affected by 
pressure changes and 2) the mucosa could be influenced by other 
bladder pathology such as carcinoma or infection. In both studies wall 
thickness was measured at a variety of filling volumes. Although both 
revealed a decrease in wall thickness with increasing filling volume, 
only the later study 8  quantified this at incremental measurements in the 
same individual. 8 DWT decreased at volumes up to 250 ml but beyond 
that point it remained relatively static. The authors recommend 
measuring DWT at a filling volume of 250 ml or greater when possible. 
Another study of asymptomatic healthy volunteers revealed a slightly 
higher mean DWT of  2mm. 28   As only a single measurement was 
taken in each patient at a filling volume of 200 ml, these results may 
reflect an underestimation of DWT. 8 Furthermore, images were 
inadequately enlarged to obtain an accurate measurement and some of 
the patients were pretreated with alpha blockers known to decrease 
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BWT/DWT. In conclusion, there is no consensus in the literature for age 
and gender specific diagnostic ranges or cut offs for BWT/DWT. 
BWT or DWT in bladder outlet obstruction [BOO] 
A handful of studies have attempted to quantify the diagnostic ability of 
transabdominal ultrasound measurements of BWT/DWT in patients with 
suspected bladder outlet obstruction. Hakenberg et al reported a mean 
bladder wall thickness of 3.67 mm in 150 men with LUTS at a variety of 
filling volumes. 26  However, no statistically significant difference was 
found between these men and age matched asymptomatic controls. In 
another study a similar mean of 4mm was obtained in 170 men with 
urodynamically confirmed bladder outlet obstruction 7   . BWT was 
measured at a single filling volume of 150 ml. A value of 5 mm 
appeared to be the best cut off to diagnose BOO, with 88% of patients 
with BWT 5 mm or greater confirmed as obstructed on pressure flow 
studies [PFS].Based on preliminary data revealing an effect of filling 
volume on DWT in healthy volunteers,  Oelke et al assessed DWT at 
bladder capacity in men with bladder outlet obstruction 28 .DWT 
increased incrementally in relation to the degree of obstruction. On 
pressure flow studies, mean DWT was 1.33, 1.62, 2.4 and greater than 3 
mm in unobstructed, equivocal, obstructed and severely obstructed 
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patients, respectively. Comparable results were reported in a similar 
study of DWT at filling capacity in 102 men with LUTS.29 Median 
DWT was 1.7, 1.8 and 2.7 mm in the unobstructed, equivocal and 
obstructed groups, respectively, with a DWT of 2.9 mm or greater 
shown to be the best cutoff to diagnose bladder outlet obstruction 
(positive predictive value 100%, specificity 100%, area under the curve 
[AUC ] 0.88). In both of these studies the difference in DWT between 
unobstructed and obstructed patients was statistically significant. 
More recently a DWT of 2 mm or greater was reported in 94% of men 
with bladder outlet obstruction confirmed on pressure flow studies at a 
filling volume of 250 ml or greater. 4   Compared  to other clinical 
parameters DWT was the best test to predict BOO with an area under 
the curve AUC of 0.93. In addition, adjusting the DWT threshold to 2.5 
mm, as reported by Kessler et al, 29  revealed similar sensitivity and 
specificity to that reported by Oelke et al.28,4 More recently, a study of 
155 Turkish men reported a statistical difference in BWT in those with a 
maximum uroflow rate of 10 ml per second or less (mean BWT 4.44 +/_ 
1.18 mm) compared to those with a rate greater than 10 ml per second 
(mean BWT 3.85+/ _0.76 mm). 30   Measurements were taken at bladder 
volumes between 150 and 200 ml. Although a consistent trend between      
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BWT / DWT and bladder outlet obstruction can be appreciated, no 
definitive reference ranges have been established.  
Ultrasound Estimated Bladder Weight 
BWT/DWT is affected by filling volume. Therefore, its usefulness as a 
clinical tool becomes limited in everyday practice. Kojima et al 
attempted to resolve 
this problem by calculating bladder weight. 10   Transabdominal 
ultrasound measurements of intravesical volume and BWT were 
obtained. Assuming the bladder to be a sphere, the bladder wall volume 
was calculated by subtracting 
the intravesical volume from the total bladder volume, which includes 
the bladder wall. The ultrasound estimated bladder weight [UEBW] was 
obtained by multiplying this parameter with the specific gravity. The 
UEBW of 10 cadaveric bladders correlated significantly with the actual 
bladder weight  
(r = 0.970, p <0.0001), and stable UEBW was observed in 16 patients 
measured repeatedly at filling volumes between 100 and 300 ml. Kojima 
et al also reported greater mean UEBW in conditions that cause BOO, 
such as benign prostatic hyperplasia, prostate cancer and urethral 
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stricture. 31   Mean UEBW was significantly higher in 34 obstructed 
men (BOO index greater than 40,mean UEBW 46.2 gm) than in 31 
unobstructed men(mean UEBW 29.3 gm). Receiver operator 
characteristic [ROC ] analysis demonstrated an UEBW cutoff of greater 
than 35 gm for predicting BOO with 87.9% of obstructed men having an 
UEBW greater than 35 gm. 
.Ochiai and Kojima correlated UEBW with ultrasonic measurement of 
prostatic size. 32   In 234 men a mean UEBW of 41.1 gm was observed 
in those with a larger prostate compared to 27.1 gm in those with a 
normal size prostate. A larger prostate and postvoid residual volume 
greater than 100 ml correlated with UEBW greater than 35 gm. In a 
longitudinal study of 33 men with benign prostatic hyperplasia mean 
UEBW decreased significantly from 52.9 to 35gm 
 4 weeks after prostatectomy compared to 26.5gm in control patients. 33   
At 12 weeks mean UEBW was 31.6 gm and had completely normalized 
in the majority of men. 
Miyashita et al studied UEBW in men with  acute urinary retention 
[AUR]. 34 Of these men 90% had an UEBW of 35 gm or greater 
compared to only 41% of those without AUR. Multivariate analysis 
revealed age and UEBW to be significant determinants of AUR, and 
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men with an UEBW greater than 35 gm were 13.4 times as likely to 
develop AUR. In a longitudinal study of men receiving tamsulosin for 
LUTS, UEBW was 35 gm or greater in approximately half. 35   At 5 
years 81.7% of these men had undergone prostatectomy compared to 
only 36.2% of those with UEBW less than 35 gm. Multivariate analysis 
demonstrated UEBW 35 gm or greater and International Prostate 
Symptom Score 20 or greater to be significant risk factors for 
proceeding to surgery. Although UEBW appears to be an attractive 
assessment method for bladder outlet obstruction, its diagnostic power 
should not be overstated. To our knowledge there is currently no 
published literature from other institutions to confirm or dispute the 
findings of Kojima etal. 31  
UEBW Automation 
One problem with the measurement technique used in all the above 
studies is that bladder weight is dependent on an experienced operator 
measuring bladder wall thickness and all the calculations have to be 
done manually. The development of a handheld device with automated 
measurement and calculation presented a great step forward. The 
BladderScan® BVM 6500 (Verathon Medical, Bothell, USA) acquires a 
V-mode ultrasound image using a 3.7 MHz transducer rotating within 
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120° cone. 36   The 3-dimensional ultrasound data is transferred into a 
computer to be analyzed using a specially developed algorithm that 
identifies the bladder region 
The inner surface of the bladder is delineated on the 3D image by the 
computer and the bladder surface area (SA) is calculated by 
triangulation. The anterior bladder wall is determined and the thickness 
(BWT) is measured automatically. Ultrasound-estimated bladder weight 
is then calculated using the formula: 
UEBW = BWT x SA x specific gravity 
The stated advantages of automated measurement of ultrasound-
estimated bladder weight are: 
1. Use of 3D rather than 2D ultrasound 
2. Calculation of the actual surface area rather than assuming a 
spherical bladder 
3. Automated and reproducible measurement 
Using data from 216 scans in 20 healthy male subjects, this approach 
estimated mean (SD) bladder weight to be 42 (6) g.  36   It is noted that 
this estimate is higher than that quoted by Kojima in normal subjects of 
29.3 (9.4) g. 37   This is explained by the fact that a sphere has the least 
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surface area for a given volume and since the bladder shape is almost 
never absolutely a sphere, the calculation using the true surface area 
would produce higher estimate of bladder weight. The variation in the 
repeated measure of automated bladder weight measurement 
corresponded with a coefficient of variation of 9%. 
A further study reported a mean (SD) normal range for ultrasound-
estimated bladder weight measured using the BladderScan® BVM 6500 
of 47.8 (9.3) g in a population based group of 359 Caucasian men (age 
range 54-92 years) from Olmsted County, USA. The study concluded 
that bladder wall thickness and surface area were better correlated with 
symptom severity score, peak flow rate, prostate volume, and PVR 
when compared to manually calculated bladder weight. However, the 
group did not state clearly the volumes at which the scans were 
performed which would have a significant bearing on both bladder wall 
thickness and bladder surface area.   38  
The accuracy of existing methods to estimate bladder weight is limited 
because of the assumption that the bladder is spherical in shape. Our 
results have shown that the bladder is significantly nonspherical in 
shape. Also, because in the existing methods the thickness is measured 
manually, the bladder wall measurements suffer from high inter- and 
intra-observer variability. 
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The main benefit of this new approach is that it produces more accurate 
and consistent estimates of  UEBW. The reasons for this include: 1) the 
use of 3D rather than 2D data to calculate bladder surface area and 
thickness, 2) the use of the true surface area instead of an assumed 
spherical surface area, and 3) the automatic and consistent 
measurements of wall thickness and surface area using advanced image 
processing algorithms. Additional benefits of this approach are its 
noninvasiveness and ease of use—UEBW is measured over a range of 
bladder volumes, thereby eliminating the need to catheterize the patient 
to fill up to a fixed volume.  since 3D ultrasound is not available in our 
institution,we calculated bladder wall thickness with the available 2D B-
mode ultrasound machine in our department.        
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MATERIALS AND METHODS 
TITLE OF THE STUDY:  
The use of ultrasound estimated bladder weight in diagnosing bladder 
outlet obstruction . 
PERIOD OF STUDY: 
January 2009 –April 2011 
STUDY DESIGN:  
Prospective study 
PLACE OF STUDY: 
The study was conducted in the Department of Urology, Rajiv Gandhi 
Government General  Hospital , Madras Medical college, Chennai. 
ETHICAL CLEARANCE: 
 The institutional ethical review board at our hospital approved the 
study. 
INCLUSION CRITERIA: 
1.Male patients above 50 years of age. 
2.History of obstructive LUTS. 
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3.Patients should not be on  foley catheter. 
EXCLUSION CRITERIA: 
1. Patients with other pathology like vesical calculus ,carcinoma 
bladder, and carcinoma prostate. 
2. Patients with past history of bladder, prostate, and  urethral surgeries. 
3 .Patients with neurogenic bladder. 
METHOD OF STUDY: 
Informed consent obtained from all the patients after explaining 
details of the study.All details were recorded in a proforma as an 
outpatient procedure. Prospective analysis done with the collected 
details. 
PATIENT EVALUATION:  
All 120 patients who satisfied the above mentioned inclusion/ exclusion 
criteria were enrolled in this study. International prostate symptoms 
score recorded for each patients with specified questionnaire. All patient 
were subjected to transabdominal ultrasonography in full bladder using 
Siemens ultrasound machine to calculate bladder volume, prostate 
volume using ellipsoid formula with 7.5 Hz high frequency probe. 
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Anterior bladder wall imaged and freezed by magnification, anterior 
bladder wall thickness measured in centimeters and recorded. Then 
patients were subjected to uroflowmetry using status uroflowmeter, post 
void residual urine calculated using trans abdominal ultrasound. Bladder 
weight then calculated using above recorded parameters applying 
formulae of sphere. 
Patients were then subjected to urodynamic evaluation to 
calculate detrusor pressure at Qmax . Abraham Griffith Number [AGN ] 
/ Bladder outlet obstruction index  [BOOI ]calculated by using the 
formula 
BOOI/ AGN = Pdet Qmax – 2 Qmax 
If >40 = Obstructed, <20 Non obstructed, 20-40 Equivocal. 
 Patients included in the study are divided into 2 groups based on 
Pressure flow studies into obstructed and non obstructed .Hence study 
group contains, 
Group I: Nonobstructed [Bladder outlet obstruction index /Abraham 
Griffith Number ≤ 20 ]  
Group II :obstructed [Bladder outlet obstruction index /Abraham 
Griffith             Number ≥ 40 ]  
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The following steps are used to measure the UEBW: 
1. Using the known filled intravesical volume, Vi, and assuming the 
bladder to be a sphere, first estimate the inner radius, ri, of the 
bladder as: 
  3Vi 
ri  =  ----- 
  4π 
2. Next, using the measured thickness, t, estimate the outer radius, ro,  
of the bladder shell as: ro = ri + t 
3. Using the outer radius, estimate the total vesical volume, Vo, as: 
  4 
Vo =  --- π r03 
  3 
4. Finally, estimate UEBW by calculating the bladder muscle volume as 
the difference between the total vesical volume and the intravesical 
volume and multiplying this bladder muscle volume with the specific 
gravity, p, of the 
bladder muscle tissue:UEBW = (Vo–Vi)p  
All the above recorded individual parameters were compared and 
analyzed against ultrasound estimated bladder weight in both obstructed 
and non obstructed groups for diagnosing bladder outlet obstruction. 
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STUDY ANALYSIS: 
The Statistical Package for the Social Sciences, version 18.0.2 (SPSS 
Inc, Chicago, IL, USA) was used for the statistical analysis. 
A p value equal to or below 0.05 was considered significant. Positive 
and 
negative predictive values, sensitivity, specificity,diagnostic accuracy, 
and the likelihood ratio of a positive or negative test result were 
calculated for DWT, Qmax, , postvoid residual urine, and prostate 
volume. Receiver operator characteristic (ROC) curves were produced 
to visualize, and calculation of the area under the curve (AUC) was used 
to describe the diagnostic characteristics of the index tests to diagnose 
bladder outlet obstruction.  
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OBSERVATION & RESULTS 
Descriptive Statistics 
 
Combined Number Minimum Maximum Mean Std. Dev Variance
Age in years 120 52.0 73.0 63.675 4.9691 24.692 
International Prostate 
symptom score 
120 5.0 26.0 13.717 6.2014 38.457 
Uroflow maximum (ml) 120 6.0 18.0 11.667 2.9911 8.947 
Post void residual (ml) 120 10.0 120.0 51.458 35.689 1273.69 
Bladder wall thickness 
(cms) 
120 0.2 0.4 0.258 0.0559 0.003 
Ultrasound estimated 
bladder weight (gms) 
120 22.0 60.0 38.321 10.5557 111.424 
Bladder outlet 
obstruction index 
(BOOI) / Abraham 
Griffith (AG) Number 
120 14.0 54.0 30.467 13.4070 179.747 
Prostate volume 120 20.0 42.0 29.300 5.3367 28.481 
  
Out study comprises of 120 male patients who presented with 
obstructive lower urinary tract symptoms and benign prostatic 
enlargement. All patients were not on foley catheter. They were in the 
age group of 52-73 years (mean age is 61.3 years), International prostate 
symptoms score between 5-26 (mean 13.7). Their uroflow ranged 
between 6-18ml (mean 11ml) post void residual urine varied between 
10-120ml (mean 51.45ml). Bladder wall thickness varied between 0.2 to 
0.4cm (mean 0.258cm). Ultrasound estimated bladder weight varied 
between 22-66gms (mean 38.32gms). Mean prostate volume is 42cc. 
 24
Age distribution
<= 59 years
24%
60 - 64 years
32%
65 - 69 years
31%
70 years or more
13%
 
 
 
 
17
12
17
21
18
19
8 8
0
5
10
15
20
25
Fr
eq
ue
nc
y
<= 59 years 60 - 64 years 65 - 69 years 70 years or more
Group wise Age distribution
Obstructed
Un-obstructed
 
 
 
 25
 
Mean age (years)
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
Obstructed Un-obstructed
Group
M
ea
n 
ag
e 
(y
ea
rs
)
 
 
 
 
Bladder outlet obstruction index (BOOI) / 
Abraham Griffith (AG) Number
0.0
10.0
20.0
30.0
40.0
50.0
Obstructed Un-obstructed
Group
O
bs
tr
uc
tio
n 
In
de
x
 26
 
Group I Non-
obstructed 
Number Minimum Maximum Mean Std. Dev Variance 
Age in years 60 53.0 73.0 64.133 5.1862 26.897 
International Prostate 
symptom score 
60 5.0 24.0 8.483 2.7831 7.745 
Uroflow maximum 
(ml) 
60 10.0 18.0 14.100 1.7143 2.939 
Post void residual (ml) 60 10.0 30.0 18.417 6.4763 41.942 
Bladder wall thickness 
(cms) 
60 .2 .3 .210 .0303 .001 
Ultrasound estimated 
bladder weight (gms) 
60 22.0 42.0 28.792 4.3250 18.706 
Bladder outlet 
obstruction index 
(BOOI) / Abraham 
Griffith (AG) Number 
60 14.0 20.0 17.367 1.9997 3.999 
Prostate volume 60 20.0 40.0 28.267 4.8916 23.928 
 
 In non obstructed group the age of the patients ranged from 53-73 
years (mean 64.13years). International prostate symptoms score  ranged 
between 5-24 (mean 8.48). Bladder wall thickness ranged between 0.2-
0.3cm (mean 0.21cm). Ultrasound Estimated Bladder Weight ranged 
between 22-42gms (mean 28.79gms). Mean prostate volume is 28cc. 
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Group II Obstructed Number Minimum Maximum Mean Std. Dev Variance
Age in years 60 52.0 72.0 63.217 4.7411 22.478 
International Prostate 
symptom score 
60 8.0 26.0 18.950 3.7571 14.116 
Uroflow maximum (ml) 60 6.0 14.0 9.233 1.7502 3.063 
Post void residual (ml) 60 40.0 120.0 84.500 17.5079 306.525 
Bladder wall thickness 
(cms) 
60 .3 .4 .307 .0252 .001 
Ultrasound estimated 
bladder weight (gms) 
60 37.0 60.0 47.850 4.6197 21.342 
Bladder outlet 
obstruction index 
(BOOI) / Abraham 
Griffith (AG) Number 
60 40.0 54.0 43.567 3.0828 9.504 
Prostate volume 60 20.0 42.0 30.333 5.5986 31.345 
 
In obstructed group age of the patient ranged between 52-72 years 
(mean 63.21 years). International prostate symptoms score ranged 
between 8-26 (mean 18.95). Bladder wall thickness varied between 0.3-
0.4cms (mean 0.30cms). Ultrasound estimated bladder weight ranged 
between 37-60gms (mean 47.85gms). Mean prostate volume 30cc. 
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Independent samples T-Test 
 
 Group Number Mean Std. Dev P-Value 
Age in years 
Obstructed 60 63.217 4.7411 
0.314 
Non-obstructed 60 64.133 5.1862 
International Prostate 
symptom score 
Obstructed 60 18.950 3.7571 
0.000 
Non-obstructed 60 8.483 2.7831 
Uroflow maximum (ml) 
Obstructed 60 9.233 1.7502 
0.000 
Non-obstructed 60 14.100 1.7143 
Post void residual (ml) 
Obstructed 60 84.500 17.5079 
0.000 
Non-obstructed 60 18.417 6.4763 
Bladder wall thickness 
(cms) 
Obstructed 60 0.307 0.0252 
0.000 
Non-obstructed 60 0.210 0.0303 
Ultrasound estimated 
bladder weight (gms) 
Obstructed 60 47.850 4.6197 
0.000 
Non-obstructed 60 28.792 4.3250 
Bladder outlet 
obstruction index 
(BOOI) / Abraham 
Griffith (AG) Number 
Obstructed 60 43.567 3.0828 
0.000 
Non-obstructed 60 17.367 1.9997 
Prostate volume 
Obstructed 60 30.333 5.5986 
0.033 
Non-obstructed 60 28.267 4.8916 
 Factors like Age, International Prostate Symptoms Score, 
Uroflow, Post void residual urine, Bladder wall thickness, Ultrasound 
estimated bladder weight and prostate volume were compared between 
non obstructed and obstructed groups. Analysing every factors by 
independent sample T-test showed significant P value of <0.0001 for 
IPSS, Uroflow, PVR, BWT, Ultrasound Estimated Bladder Weight in 
obstructed group. 
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Simple linear Regression Analysis  
Dependent Variable: Bladder outlet obstruction index (BOOI) / Abraham Griffith 
(AG) Number 
Model Summary 
 
Predictors Constant Regression Co-efficient 
P-
Value R 
R 
Square
Ultrasound estimated 
bladder weight (gms) 
-13.191 1.139 0.000 0.897 0.805 
International Prostate 
symptom score 
5.266 1.837 0.000 0.850 0.722 
Uroflow maximum (ml) 73.020 -3.647 0.000 -0.814 0.662 
Post void residual (ml) 12.633 0.347 0.000 0.923 0.851 
Bladder wall thickness 
(cms) 
-21.478 201.08 0.000 0.838 0.703 
Prostate volume 16.607 0.473 0.039 0.188 0.035 
 
 30
Regression Curve 
 
 
 
 Ultrasound Estimated Bladder Weight of >39.5gms had 96.6% 
sensitivity, 98.3% specificity, 97.5% diagnostic accuracy of predicting 
bladder outlet obstruction in patients presenting with obstructive lower 
urinary tract symptoms and benign prostatic hyperplasia. Applying this 
Ultrasound estimated bladder weight 59 out of 60 patients fall in 
obstructed group. Area under the curve analysis (AUC) revealed a value 
of 0.996 for Ultrasound estimated bladder weight of 39.5gms which is 
most significant in diagnosing bladder outlet obstruction. 
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Sensitivity and Specificity 
 
 
Group
Total 
Non-obstructed Obstructed 
UEBW 
Nonobstructed 
(< 39.5) 
58 1 59 
Obstructed 
(≥ 39.5) 2 59 61 
Total 60 60 120 
 
 
 
 
 
Measurement Estimate (%) 
95% CI 
(%) 
Sensitivity 96.67 (88.64, 99.08) 
Specificity 98.33 (91.14, 99.71) 
Positive Predictive Value 98.31 (91, 99.7) 
Negative Predictive Value 96.72 (88.81, 99.1) 
Diagnostic Accuracy 97.5 (92.91, 99.15) 
Likelihood ratio of a Positive Test 58 (8.16 - 412.2) 
Likelihood ratio of a Negative Test 0.0339 (0.01272 - 0.09037) 
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ROC Curve 
 
 
 
 
 
Area Under the Curve
Test Result Variable(s):Ultrasound estimated bladder weight (gms) 
Area 
0.996 
The test result variable(s): Ultrasound estimated bladder weight (gms) has at least 
one tie between the positive actual state group and the negative actual state group. 
Statistics may be biased. 
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Regression Curve 
 
 
 International prostate symptoms score of >13 had 98% sensitivity, 
95% specificity and 96% diagnostic accuracy in predicting bladder 
outlet obstruction among obstructed group. Area under the curve 
analysis revealed a value of 0.976 which is significant. 
International Prostate Symptom Score
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Sensitivity and Specificity 
 
 
Group 
Total 
Non-obstructed Obstructed
IPSS 
Nonobstructed
(< 13.0)
59 3 62 
Obstructed 
(≥ 13.0) 1 57 58 
Total 60 60 120 
 
 
Measurement Estimate (%) 
95% CI 
(%) 
Sensitivity 98.33 (91.14, 99.71 ) 
Specificity 95.00 (86.3, 98.29 ) 
Positive Predictive Value 95.16 (86.71, 98.34 ) 
Negative Predictive Value 98.28 (90.86, 99.7 ) 
Diagnostic Accuracy 96.67 (91.74, 98.7 ) 
Likelihood ratio of a Positive Test 19.67 (10.23 - 37.82) 
Likelihood ratio of a Negative Test 0.01754 (0.002467 - 0.1248) 
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ROC Curve 
 
 
 
 
 
Area Under the Curve
Test Result Variable(s):International Prostate symptom score
Area 
0.976
The test result variable(s): International Prostate symptom score has at least one tie 
between the positive actual state group and the negative actual state group. 
Statistics may be biased. 
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Regression Curve 
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ROC Curve 
 
 
 
Area Under the Curve 
Test Result Variable(s):Uroflow maximum (ml) 
Area 
0.031 
The test result variable(s): Uroflow maximum (ml) has at least one tie between 
the positive actual state group and the negative actual state group. Statistics may 
be biased. 
 
By area under the curve analysis, uroflow calculation has value of only 
0.031, which is not significant in calculating bladder outlet obstruction 
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Regression Curve 
 
Post void residual urine volume of >50ml had 100% sensitivity, 
98% specificity and 99% diagnostic accuracy in predicting bladder 
outlet obstruction among obstructed group. Area under the curve 
analysis showed a value of 1.000 which is most significant. 
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Sensitivity and Specificity 
 
 
Group 
Total 
Non-obstructed Obstructed 
PVR 
Nonobstructed 
(< 50.0) 
60 1 61 
Obstructed 
(≥ 50.0) 0 59 59 
Total 60 60 120 
 
 
 
 
Measurement Estimate (%) 
95% CI 
(%) 
Sensitivity 100.00 (93.98, 100) 
Specificity 98.33 (91.14, 99.71) 
Positive Predictive Value 98.36 (91.28, 99.71) 
Negative Predictive Value 100.00 (93.89, 100) 
Diagnostic Accuracy 99.17 (95.43, 99.85) 
Likelihood ratio of a Positive Test 60 (8.5 - 426) 
Likelihood ratio of a Negative Test 0.0 (0.0 – 0.0) 
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ROC Curve 
 
 
 
 
Area Under the Curve
Test Result Variable(s):Post void residual (ml) 
Area 
1.000 
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Regression Curve 
 
Bladder Wall Thickness of >0.25cm has 90% sensitivity, 100% 
specificity and 95% diagnostic accuracy in predicting bladder outlet 
obstruction among obstructed group. Area under the curve analysis 
showed a value of 0.953 which is most significant. 
Bladder wall thickness 
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Sensitivity and Specificity 
 
 
Group 
Total 
Non-obstructed Obstructed
BWT 
Nonobstructed
(< 0.25) 
54 0 54 
Obstructed 
(≥ 0.25) 6 60 66 
Total 60 60 120 
 
 
 
 
Measurement Estimate (%) 
95% CI 
(%) 
Sensitivity 90.00 (79.85, 95.34) 
Specificity 100.00 (93.98, 100) 
Positive Predictive Value 100.00 (93.36, 100) 
Negative Predictive Value 90.91 (81.55, 95.77) 
Diagnostic Accuracy 95.00 (89.52, 97.69) 
Likelihood ratio of a Positive Test undefined  
Likelihood ratio of a Negative Test 0.1 (0.07213 - 0.1386) 
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ROC Curve 
 
 
 
 
 
 
Area Under the Curve
Test Result Variable(s):Bladder wall thickness (cms)
Area
0.953 
The test result variable(s): Bladder wall thickness (cms) has at least one tie 
between the positive actual state group and the negative actual state group. 
Statistics may be biased. 
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Regression Curve 
 
  
Area under the curve analysis of  prostate volume showed a value 
of 0.601 which is not much significant in diagnosing bladder outlet 
obstruction. 
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ROC Curve 
 
 
 
 
 
Area Under the Curve 
Test Result Variable(s):Prostate volume 
Area 
0.601 
The test result variable(s): Prostate volume has at least one tie between the positive 
actual state group and the negative actual state group. Statistics may be biased. 
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                                            DISCUSSION 
Lower urinary tract symptoms and bladder outlet obstruction is the 
commonest problem in urological practice.The definitive preoperative 
diagnosis of infravesical obstruction would contribute much toward 
consideration of treatment options for patients with urinary symptoms 
and decrease the number of surgical treatment failures significantly. In 
the past many efforts have been made to establish diagnostic standards 
capable of evaluating infravesical obstruction objectively.39  The 
American Urological Association symptom index for BPH was reported 
to show a high correlation to patient global ratings of the magnitude of 
urinary disturbance caused by BPH and to discriminate strongly 
between BPH and control subjects.40  
Netto et a1 examined the relationship between the International Prostatic 
Symptom Score (I-PSS) 41 and infravesical obstruction caused by 
BPH.42  
Of their 111 patients with severe symptoms (scores 20 to 35) 92(82.9%) 
had bladder outlet obstruction caused by BPH compared to 53.4% of 
those with moderate symptoms (scores 8 to19). They concluded that I-
PSS cannot be used for diagnosing prostatic obstruction but it can 
provide an important means 
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of selecting patients who should undergo further urodynamics,that is 
pressure-flow studies. The authors recommended pressure-flow studies 
only in patients with a total I-PSS of less than 28. However, it is likely 
that the well-known lack of gender 43, 44 and disease  45 specificities of 
the symptom index  to BPH makes it unreliable for predicting 
infravesical obstruction. 
Uroflowmetry because of its noninvasiveness and easy to perform  has 
commonly been used in the diagnostic evaluation of infravesical 
obstruction but with confusing results.46-49 Siroky et al developed a flow 
rate nomogram relating bladder volume to maximum flow rate and 
reported a clear separation of patients with infravesical obstruction from 
the normal population using the nomogram 47 
In a study of 65 men with LUTS conducted by  Kojima et al , 
ultrasound-estimated bladder weight correlated with the Abrams-
Griffiths number 
 (r = 0.478, P<0.0001) . Mean (SD) bladder weight in the obstructed 
group was 46.2 (13.3) g which was significantly higher than that in the 
unobstructed group [29.3 (9.4) g, P<0.0001]. 31 Receiver operator 
characteristic (ROC) analysis suggested that a cut off value for 
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ultrasound-estimated bladder weight of 35 g had 85% sensitivity and 
87% specificity for diagnosis of obstruction. 
In our study of 120 men with obstructive lower urinary tract symptoms 
mean (SD) bladder weigh in the obstructed group was 47.85 (4.6gms) 
which was significantly higher than in non obstructed group 28.79 
(4.3g); P<0.0001. Receiver operator characteristic (ROC) analysis 
suggested that a cut off value of 39.5g has 96% sensitivity, 98% 
specificity, 97.5% diagnostic accuracy for predicting bladder outlet 
obstruction. Our results are comparable with Kojima et al study in 
diagnosing bladder outlet obstruction. 
Kojima et al, also studied ultrasound-estimated bladder weight as a 
predictor of acute urinary retention (AUR) in a group of 160 men 
presenting with LUTS, 31 of whom suffered AUR. Patients presenting 
with AUR had higher mean (SD) ultrasound-estimated bladder weight at 
50.5 (15.5) g than those presenting with LUTS but with good bladder 
emptying [34.7 (13.6) g, P<0.0001]. Again using analysis of the ROC 
curve, a cut off value of 40 g was used to predict the presence of AUR 
giving a sensitivity of 74% and specificity of 71%. 34 
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In out study ultra sound estimated bladder weight is not studied as a 
predictor for acute urinary retention developing during follow up of 
patients. 
A larger group of 234 patients were recruited by Ochai et al,to study the 
relationship between ultrasound-estimated bladder weight and other 
relevant variables including AUA symptom score, maximum flow rate 
(Q max ), post-void residual (PVR) and presumed circle area ratio of the 
prostate. Multiple regression analysis showed that PVR (r = 0.490, 
P<0.0001) and presumed circle area of prostate (r = 0.468, P <0.0001) 
were significant independent determinants of ultrasound-estimated 
bladder weight.32  
In out study by multiple regression analysis relationship between 
ultrasound estimated bladder weight and other relevant variables 
analyzed. It showed that International prostate symptoms score of 
(r=0.850, P=0.0001) Post void residual urine (r=0.923, P=0.0001) and 
Bladder wall thickness (r=0.838, P=0.0001) were significant 
independent determinants of ultrasound estimated bladder weight in 
calculating bladder outlet obstruction. So our results are comparable to 
Ochai et al study. 
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Guzman et al. presented data from 30 men with confirmed bladder 
outlet obstruction diagnosed using the Schafer nomogram. The results 
showed that ultrasound-estimated bladder weight correlated positively 
with the international prostate symptom score (IPSS; r = 0.710, P = 
0.0012) and with maximum detrusor pressure (r = 0.710, P = 0.299) and 
it correlated negatively with Q max (r = -0.873, P = 0.00001). 
Nevertheless there was no significant correlation between the bladder 
weight and the residual urine. 50 
In our study by multiple regression analysis, Receiver operator 
characteristic (ROC) curves analysis and calculation of the area under 
the curve (AUC) , ultrasound-estimated bladder weight correlated 
positively with the international prostate symptom score [IPSS], 
Uroflow, Postvoid residual urine and bladder wall thickness [BWT] and 
it correlated negatively with prostate volume.  
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CONCLUSION 
 Ultrasound Estimated Bladder Weight can be used as a non invasive 
bedside test to diagnose bladder outlet obstruction in elderly men having 
benign prostatic hyperplasia and presenting with obstructive urinary 
symptoms. 
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THE USE OF ULTRASOUND ESTIMATED BLADDER WEIGHT IN  
 
DIAGNOSING BLADDER OUTLET OBSTRUCTION 
  
PROFORMA 
  
NAME:                                                               AGE & SEX 
 
ADDRESS: 
 
 
PHONE NO:                                                           URO  NO:            
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 LUTS; 
 
 
DM/HT/PT                                                      H/O DRUG INTAKE 
 
 
PREVIOUS INTERVENTION/ SURGERY 
 
G/E:: 
 
GENITALIA: 
 
P.R: 
 
INVESTIGATIONS: 
 
 
IPSS QUESTIONNAIRE 
 
 
USG-KUB 
 
 
UROFLOW 
 
 
PVR 
 
 
PRESSURE-FLOW STUDIES 
 
                                                              
                                                     MASTER CHART 
                        
S.NO AGE IPSS QMAX PVR BWT UEBW AG NO PR.VOL 
1 52 18 8 80 0.3 44.5 42 40 
2 55 23 6 100 0.4 58 46 36 
3 60 12 12 40 0.3 37 42 32 
4 59 18 7 80 0.3 45 40 24 
5 66 16 6 90 0.3 48.5 44 28 
6 60 22 9 100 0.3 46 44 42 
7 58 24 8 90 0.3 48 48 28 
8 66 24 8 80 0.4 59 42 26 
9 65 18 9 70 0.3 40 40 20 
10 70 20 6 90 0.3 42 44 28 
11 67 14 10 80 0.3 41 40 32 
12 62 8 12 60 0.3 40 44 36 
13 59 16 10 100 0.3 44 42 30 
14 69 15 8 80 0.3 43 40 30 
15 70 22 7 100 0.3 45 46 28 
16 63 18 12 75 0.3 46 42 24 
17 68 16 10 60 0.3 44 40 22 
18 67 16 9 80 0.3 46 42 32 
19 69 16 10 120 0.3 48 44 36 
20 72 20 8 80 0.3 48 46 30 
21 56 18 8 90 0.3 47 40 30 
22 61 16 14 60 0.3 49 44 36 
23 65 18 9 100 0.3 48 48 32 
24 71 20 8 85 0.3 49 40 28 
25 70 16 8 80 0.3 46 42 28 
26 68 18 10 100 0.3 50 44 26 
27 65 20 14 70 0.3 48 42 36 
28 67 22 10 100 0.3 48 40 22 
29 66 24 8 120 0.3 51 46 24 
30 62 18 10 100 0.3 47 42 28 
31 59 14 10 80 0.3 46 40 32 
32 59 22 9 90 0.3 50 46 34 
33 58 12 10 70 0.3 50 48 36 
34 63 19 9 110 0.3 51 46 40 
35 57 18 10 80 0.3 51 42 38 
36 64 22 8 95 0.3 53 48 30 
37 64 24 10 100 0.3 53 46 32 
38 70 26 10 90 0.3 53 44 42 
39 60 16 11 70 0.3 55 42 40 
40 70 14 10 60 0.3 50 44 38 
41 63 14 10 60 0.3 45 42 24 
42 59 16 9 75 0.3 50 46 24 
43 65 20 8 80 0.3 46 44 28 
44 67 16 12 100 0.3 49 40 34 
S.NO AGE IPSS QMAX PVR BWT UEBW AG NO PR.VOL 
45 58 20 8 80 0.3 45 40 32 
46 68 16 8 70 0.4 56 40 36 
47 62 22 10 100 0.3 46 44 28 
48 59 18 10 60 0.3 44 44 24 
49 65 24 12 90 0.3 42 40 22 
50 59 22 10 60 0.3 45 48 28 
51 61 22 10 120 0.4 60 48 30 
52 63 20 7 80 0.3 42 48 32 
53 57 22 6 65 0.3 44 40 32 
54 65 20 10 85 0.3 49 46 36 
55 56 24 8 60 0.3 48 54 30 
56 60 22 10 75 0.3 46 40 30 
57 70 18 8 85 0.3 54 40 24 
58 64 18 9 110 0.3 48 48 28 
59 63 24 8 120 0.3 51 46 20 
60 57 26 10 90 0.3 53 44 22 
61 64 6 15 20 0.2 23 16 24 
62 63 7 14 30 0.2 25 18 30 
63 57 6 12 20 0.2 28 18 28 
64 67 5 14 10 0.2 30.5 16 32 
65 62 7 14 10 0.3 38 14 36 
66 65 10 12 20 0.2 24 18 30 
67 54 10 14 10 0.2 23 18 28 
68 56 8 12 20 0.3 39 16 26 
69 53 10 12 30 0.3 42 16 22 
70 64 7 14 10 0.2 22 16 24 
71 67 12 10 30 0.3 38 14 40 
72 69 6 12 20 0.2 25 18 32 
73 63 10 15 20 0.2 25 16 30 
74 72 6 15 10 0.2 25 14 34 
75 70 7 14 20 0.2 27 16 36 
76 65 6 14 10 0.2 26 20 28 
77 59 6 16 15 0.2 28 18 26 
78 63 6 14 20 0.2 27 20 22 
79 73 6 14 15 0.2 28 20 20 
80 63 8 13 15 0.2 29 20 28 
81 60 8 12 25 0.2 28 18 24 
82 56 7 16 15 0.2 26 14 22 
83 63 8 14 15 0.2 28 18 20 
84 59 8 14 20 0.2 29 20 24 
85 66 6 14 10 0.2 28 18 30 
86 59 10 16 25 0.2 29 16 32 
87 67 9 16 15 0.2 29 20 34 
88 69 6 12 25 0.2 31 18 36 
89 65 8 14 10 0.2 30 18 30 
90 69 7 16 15 0.2 30 16 30 
S.NO AGE IPSS QMAX PVR BWT UEBW AG NO PR.VOL 
91 72 10 18 15 0.2 29 20 30 
92 71 8 16 25 0.2 31 14 32 
93 73 6 11 30 0.2 32 18 34 
94 69 10 14 15 0.2 31 20 36 
95 62 9 15 15 0.2 28 20 28 
96 68 10 16 25 0.2 28 18 24 
97 61 10 15 25 0.2 31 18 22 
98 72 10 14 25 0.2 31 20 30 
99 61 10 12 15 0.2 29 18 28 
100 64 12 15 20 0.2 27 16 32 
101 60 24 14 25 0.2 24 16 34 
102 64 8 16 10 0.2 27 14 36 
103 60 8 16 10 0.2 26 18 30 
104 56 10 16 25 0.2 25 18 28 
105 57 8 14 10 0.2 26 16 24 
106 69 10 16 25 0.2 25 14 22 
107 62 10 14 10 0.2 25 20 20 
108 63 12 12 15 0.2 27 20 24 
109 69 10 15 25 0.2 31 18 26 
110 61 10 12 15 0.2 28 16 28 
111 69 12 16 25 0.2 27 14 30 
112 73 10 16 15 0.2 31 20 32 
113 62 7 14 10 0.3 38 14 34 
114 58 10 12 30 0.3 42 16 20 
115 67 6 12 20 0.2 25 18 22 
116 68 7 14 20 0.2 27 16 24 
117 57 6 18 15 0.2 28 18 26 
118 61 6 14 15 0.2 28 20 28 
119 69 8 14 15 0.2 28 18 30 
120 68 6 11 30 0.2 32 18 24 
IPSS –INTERNATIONAL PROSTATE SYMPTOM SCORE 
QMAX- PEAK FLOW RATE –IN ML/SECONDS 
PVR- POSTVOID RESIDUAL URINE –IN ML 
BWT- BLADDER WALL THICKNESS –IN CENTIMETER 
UEBW- ULTRASOUND ESTIMATED BLADDER WEIGHT –IN GRAMS 
AG NO-ABRAHAM GRIFFITH NUMBER 
PR VOL- PROSTATE VOLUME –IN CC 
